This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Khan brings to PepsiCo over 20 years of experience in the medical and pharmaceutical field. Most recently, he served as president, Takeda Pharmaceuticals Global Research and Development Center. He built Takeda's U.S. medical affairs and global medical affairs functions, and helped develop the strong, scientific basis for launching the company's major products as president of U.S. and European drug development.
"Mehmood is an accomplished medical professional with a proven R&D track record, and I am proud and delighted to welcome him to PepsiCo," said Nooyi.